Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using ...
The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what ...
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs ...
Diana Canto-Sims, OD, introduces the second guest of Season 2, Raphael Rostenne, who will be discussing AI-assisted front desk management. For Episode 7 of The Independent Advantage’s Season 2, Diana ...
The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared ...
Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results